🔴 Quantum BioPharma is trading 7.12% down in after-hours trading despite broader biotech M&A speculation

Quantum BioPharma is trading 7.12% down at $3.00, with no verified company-specific announcement or earnings release identified for August 6.

• The regular session closed at $3.23 on August 6, 2026.
• The broader biotech sector strengthened as argenx formally commenced its $2.2 billion tender offer for Forte Biosciences, reinforcing M&A speculation.
• That sector enthusiasm did not carry into Quantum BioPharma’s after-hours trading.